To further investigate the physiological relevance of miR-124/Stat3 regulation in radiotherapy resistance, we used qPCR to measure the expression of Stat3 and miR-124 in 10 relapsed (non-responder) and 10 recurrence-free HER2-positive breast cancer patients after radiotherapy. This evidence concerns the gene ERBB2 and breast carcinoma.